Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Painsi, C; Patscheider, M; Inzinger, M; Lange-Asschenfeldt, B; Quehenberger, F; Wolf, P.
Patient perspectives on treating psoriasis with classic inpatient dithranol therapy: a retrospective patient survey.
J Dtsch Dermatol Ges. 2015; 13(11):1156-1163
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Inzinger Martin
Painsi Clemens
Quehenberger Franz
Wolf Peter

Dimensions Citations:

Plum Analytics:
Evidence of the efficacy of dithranol and patient perspectives on the treatment is scant. Using a telephone interview survey, we collected retrospective data from 63 patients (41 men [65.1 %] and 22 women [34.9 %]) who had been treated with classic inpatient dithranol (CID). PsoRA ( was used to obtain clinical data and treatment responses, which were then correlated with the interview responses. Fifty-two (82.5 %) patients achieved a PASI75 and 51 (81 %) a PASI90 response within a median of 12.5 (range: 3 to 25) days. Ten out of twelve (83 %) patients showed a satisfactory response to CID (PASI75 or greater reduction) despite the fact that they had previously failed to adequately respond to methotrexate, oral retinoids, cyclosporine, or ustekinumab. Overall, patients recalled a median recurrence-free interval of four (95 % CI: 3-9) months after responding to CID, which was positively correlated with the patients' recommendation of (p = 0.018) and their overall high satisfaction with the treatment (p = 0.012). Despite the known limitations of CID, this survey indicates that dithranol remains a highly efficacious and valuable treatment option as induction therapy in psoriasis. CID can be effective in patients who have failed to respond to systemic therapy, including traditional agents and biologics. © 2015 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Age Distribution -
Aged -
Anthralin - therapeutic use
Anthralin - epidemiology
Dermatologic Agents - therapeutic use
Female -
Health Care Surveys -
Hospitalization - statistics & numerical data
Humans -
Male -
Middle Aged -
Patient Participation - psychology
Patient Participation - statistics & numerical data
Patient Satisfaction - statistics & numerical data
Prevalence -
Psoriasis - drug therapy
Psoriasis - epidemiology
Psoriasis - psychology
Quality of Life - psychology
Retrospective Studies -
Risk Factors -
Sex Distribution -
Young Adult -

© Meduni Graz Impressum